One of the reasons given by the Chair of Brainchip for considering the move to a US Registry and removal from the ASX was apparent difficulties with making announcements on the ASX. I have an expressed position which is different to Brainchip on what they can or cannot announce however just now the following post concerning this very issue appeared on the IMU threads which appears to support Brainchip's argument. This post may or may not be correct however the poster Steini has been around for a very long time on HC so I personally expect it is factual.
My opinion only DYOR
Fact Finder
"Look what happened to CHM last week;
Here the anns on LinkedIn which is aworld first
CHM CDH17 Phase 1/2 Trial Update
Chimeric Therapeutics is pleased to provide an update on progress of its CHM CDH17 Phase 1/2 clinical trial to date. Of the three patients dosed at the first dose level of 50 million cells, two patients have achieved Stable Disease, whereby the cancer is neither increasing nor decreasing in extent or severity, with the tumours remaining at approximately the same size with no new tumours appearing. Interestingly, evidence of immune activation of CHM CDH17 CAR-T cells was observed with exceptional expansion and persistence beyond 28 days. Clinical evidence of tumour necrosis was observed, however additional results are required to determine the outcome.
And then that happened, refused by the ASX to be released
Thank you for your enquiry.
The disclosure you refer to was determined following consultation with our professional advisers and the ASX.
The information published on LinkedIn was not considered to be sufficiently ‘market sensitive’ to justify being released on ASX as a standalone announcement.The Company was reminded of provisions in the ASX Listing Rule Guidance Notes deterring companies from lodging non-market sensitive announcements on ASX.
As the information was determined not to be market sensitive from an ASX perspective, and unable to be released on ASX in a standalone announcement, the Companyshared the information on social media and a standard media release.
Thank you for your interest and ongoing support of Chimeric.
Regards
Most likely IMU's ann attempt got shut down as well.
(20min delay)